查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球数字生物标誌物市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测
市场调查报告书
商品编码
1346868

全球数字生物标誌物市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

Global Digital Biomarkers Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 281 Pages | 商品交期: 最快1-2个工作天内

价格

全球数字生物标记市场需求预计将从 2022 年的 36 亿美元增至 2030 年的近 194.8 亿美元，2023-2030 年研究期间复合年增长率为 23.5%。

数字生物标记是指通过数字设备和技术（包括可穿戴设备、智能手机、传感器和其他联网工具）收集的可测量和可量化的健康相关数据。这些数据点用于实时监控和分析个人健康和行为的各个方面。这些生物标誌物为人们的生理、心理和行为模式提供了宝贵的见解，使医疗保健专业人员和研究人员能够更全面地了解他们的健康状况。

市场动态：

由于多种因素推动技术融入医疗保健，数字生物标记市场正在经历强劲增长。可穿戴设备、远程监控和数据分析的进步使得实时健康数据的收集成为可能，为数字生物标记物奠定了基础。这些生物标誌物有助于个性化医疗保健、预防方法和健康问题的早期发现。智能手机的广泛采用，加上人口老龄化和慢性疾病的增加，刺激了对远程监控解决方案的需求。这些生物标誌物还在心理健康监测和临床试验中发挥了作用，而监管支持和消费者意识进一步推动了它们的采用。儘管如此，数据隐私和准确性等挑战仍然需要引起关注。技术、医疗保健需求和患​​者赋权的融合支撑着不断扩大的数字生物标誌物市场，彻底改变了医疗保健服务和研究方法。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球数字生物标记市场的每个细分市场进行了包容性评估。数字生物标誌物行业的增长和趋势为这项研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲数字生物标记市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。数字生物标誌物市场的主要参与者包括ActiGraph LLC、AliveCor Inc.、Koneksa、Altoida Inc.、Amgen Inc.、Biogen Inc.、Empatica Inc.、Vivo Sense、IXICO plc、Aderium Limited、Neurotrack Technologies, Inc.、 Aural Analytic、Huma、Sonde Health, Inc. 本部分包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、合作、新产品开发、新产品发布、以及其他进展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市场亮点
  • 全球市场概况

第 3 章：数字生物标记 - 行业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 行业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 通过临床实践进行的市场吸引力分析
    • 按治疗领域分類的市场吸引力分析
    • 按最终用途分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原材料分析
    • 原材料清单
    • 原料厂商清单
    • 主要原材料价格走势
  • 潜在买家名单
  • 营销渠道
    • 直效行销
    • 间接营销
    • 营销渠道发展趋势

第 5 章：全球数字生物标誌物市场分析：按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 穿戴式
  • 基于移动的应用程序
  • 传感器
  • 其他的

第 6 章：全球数字生物标誌物市场分析：根据临床实践

  • 临床实践概述
  • 历史和预测数据
  • 临床实践分析
  • 诊断数字生物标誌物
  • 监测数字生物标誌物
  • 预测和预后数字生物标誌物
  • 其他（安全性、药效动力学/反应、敏感性）

第 7 章：全球数字生物标誌物市场分析：按治疗领域

  • 按治疗领域概述
  • 历史和预测数据
  • 按治疗领域分析
  • 心血管和代谢紊乱 (CVMD)
  • 呼吸系统疾病
  • 精神疾病
  • 睡眠与运动疾病
  • 神经系统疾病
  • 肌肉骨骼疾病
  • 其他（糖尿病、疼痛管理）

第 8 章：全球数字生物标誌物市场分析：按最终用途

  • 按最终用途分類的概述
  • 历史和预测数据
  • 按最终用途分析
  • 医疗保健公司
  • 医疗保健机构
  • 付款人
  • 其他（患者、护理人员）

第 9 章：全球数字生物标誌物市场分析：按地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史和预测数据销售分析
    • 北美按细分市场销售分析
    • 北美按国家/地区销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史和预测数据销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家/地区销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 意大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史和预测数据销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳大利亚销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史和预测数据销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家/地区销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史和预测数据销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙特阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：数字生物标记公司的竞争格局

  • 数字生物标誌物市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 公司股份分析
  • 市场集中度
  • ActiGraph LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AliveCor Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Koneksa
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Altoida Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Amgen Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Biogen Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Empatica Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Vivo Sense
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • IXICO plc
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Adherium Limited
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Neurotrack Technologies Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Aural Analytic
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Huma
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sonde Health Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

Product Code: VMR112111961

The global demand for Digital Biomarkers Market is presumed to reach the market size of nearly USD 19.48 BN by 2030 from USD 3.6 BN in 2022 with a CAGR of 23.5% under the study period 2023 - 2030.

Digital biomarkers refer to measurable and quantifiable health-related data collected through digital devices and technologies, including wearables, smartphones, sensors, and other connected tools. These data points are used to monitor and analyze various aspects of an individual's health and behaviour in real time. These biomarkers provide valuable insights into a person's physiological, psychological, and behavioural patterns, enabling healthcare professionals and researchers to obtain a more holistic understanding of their well-being.

MARKET DYNAMICS:

The Digital biomarkers market is experiencing robust growth due to a combination of factors propelling the integration of technology into healthcare. Advancements in wearable devices, remote monitoring, and data analytics enable the collection of real-time health data, forming the basis for digital biomarkers. These biomarkers facilitate personalized healthcare, preventive approaches, and early detection of health issues. The wide adoption of smartphones, coupled with an ageing population and rising chronic diseases, fuels the demand for remote monitoring solutions. These biomarkers also find utility in mental health monitoring and clinical trials, while regulatory support and consumer awareness further drive their adoption. Nonetheless, challenges like data privacy and accuracy necessitate attention. The convergence of technology, healthcare needs, and patient empowerment underpins the expanding Digital biomarkers market, revolutionizing healthcare delivery and research methodologies.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of digital biomarkers. The growth and trends of digital biomarkers industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the digital biomarkers market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Wearable
  • Mobile Based Applications
  • Sensors
  • Others

By Clinical Practice

  • Diagnostic Digital Biomarkers
  • Monitoring Digital Biomarkers
  • Predictive And Prognostic Digital Biomarkers
  • Other'S (Safety, Pharmaco Dynamics/ Response, Susceptibility)

By Therapeutic Area

  • Cardiovascular And Metabolic Disorders (CVMD)
  • Respiratory Disorders
  • Psychiatric Disorders
  • Sleep & Movement Disease
  • Neurological Disorders
  • Musculoskeletal Disorders
  • Others (Diabetes, Pain Management)

By End-Use

  • Healthcare Companies
  • Healthcare Providers
  • Payers
  • Others (Patient, Caregivers)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Digital Biomarkers market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Digital Biomarkers market include ActiGraph LLC, AliveCor Inc., Koneksa, Altoida Inc., Amgen Inc., Biogen Inc., Empatica Inc., Vivo Sense, IXICO plc, Adherium Limited, Neurotrack Technologies, Inc., Aural Analytic, Huma, Sonde Health, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DIGITAL BIOMARKERS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Clinical Practice
    • 3.7.3 Market Attractiveness Analysis By Therapeutic Area
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Wearable Historic and Forecast Sales by Regions
  • 5.5 Mobile Based Applications Historic and Forecast Sales by Regions
  • 5.6 Sensors Historic and Forecast Sales by Regions
  • 5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY CLINICAL PRACTICE

  • 6.1 Overview by Clinical Practice
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Clinical Practice
  • 6.4 Diagnostic Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.5 Monitoring Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.6 Predictive And Prognostic Digital Biomarkers Historic and Forecast Sales by Regions
  • 6.7 Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Historic and Forecast Sales by Regions

7 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY THERAPEUTIC AREA

  • 7.1 Overview by Therapeutic Area
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Therapeutic Area
  • 7.4 Cardiovascular And Metabolic Disorders (CVMD) Historic and Forecast Sales by Regions
  • 7.5 Respiratory Disorders Historic and Forecast Sales by Regions
  • 7.6 Psychiatric Disorders Historic and Forecast Sales by Regions
  • 7.7 Sleep & Movement Disease Historic and Forecast Sales by Regions
  • 7.8 Neurological Disorders Historic and Forecast Sales by Regions
  • 7.9 Musculoskeletal Disorders Historic and Forecast Sales by Regions
  • 7.10. Others (Diabetes, Pain Management) Historic and Forecast Sales by Regions

8 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY END-USE

  • 8.1 Overview by End-Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-Use
  • 8.4 Healthcare Companies Historic and Forecast Sales by Regions
  • 8.5 Healthcare Providers Historic and Forecast Sales by Regions
  • 8.6 Payers Historic and Forecast Sales by Regions
  • 8.7 Others (Patient, Caregivers) Historic and Forecast Sales by Regions

9 . GLOBAL DIGITAL BIOMARKERS MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE DIGITAL BIOMARKERS COMPANIES

  • 10.1. Digital Biomarkers Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF DIGITAL BIOMARKERS INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. ActiGraph LLC
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. AliveCor Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Koneksa
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Altoida Inc.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Amgen Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Biogen Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Empatica Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Vivo Sense
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. IXICO plc
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Adherium Limited
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Neurotrack Technologies Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Aural Analytic
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Huma
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Sonde Health Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Wearable Market Sales by Geography (USD MN)
  • Mobile Based Applications Market Sales by Geography (USD MN)
  • Sensors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis Market by Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales by Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Market Sales by Geography (USD MN)
  • Analysis by Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Psychiatric Disorders Market Sales by Geography (USD MN)
  • Sleep & Movement Disease Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Musculoskeletal Disorders Market Sales by Geography (USD MN)
  • Others (Diabetes, Pain Management) Market Sales by Geography (USD MN)
  • Analysis by End-Use (USD MN)
  • Healthcare Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Payers Market Sales by Geography (USD MN)
  • Others (Patient, Caregivers) Market Sales by Geography (USD MN)
  • Global Digital Biomarkers Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Digital Biomarkers Report
  • Market Research Process
  • Market Research Methodology
  • Global Digital Biomarkers Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Clinical Practice
  • Market Attractiveness Analysis by Therapeutic Area
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Wearable Market Sales by Geography (USD MN)
  • Mobile Based Applications Market Sales by Geography (USD MN)
  • Sensors Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Clinical Practice (USD MN)
  • Diagnostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Monitoring Digital Biomarkers Market Sales by Geography (USD MN)
  • Predictive And Prognostic Digital Biomarkers Market Sales by Geography (USD MN)
  • Other's (Safety, Pharmaco Dynamics/ Response, Susceptibility) Market Sales by Geography (USD MN)
  • Global Market Analysis by Therapeutic Area (USD MN)
  • Cardiovascular And Metabolic Disorders (CVMD) Market Sales by Geography (USD MN)
  • Respiratory Disorders Market Sales by Geography (USD MN)
  • Psychiatric Disorders Market Sales by Geography (USD MN)
  • Sleep & Movement Disease Market Sales by Geography (USD MN)
  • Neurological Disorders Market Sales by Geography (USD MN)
  • Musculoskeletal Disorders Market Sales by Geography (USD MN)
  • Others (Diabetes, Pain Management) Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Healthcare Companies Market Sales by Geography (USD MN)
  • Healthcare Providers Market Sales by Geography (USD MN)
  • Payers Market Sales by Geography (USD MN)
  • Others (Patient, Caregivers) Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.